Palantir Technologies recently announced several partnerships, including with Everfox to enhance classified software solutions and with R1 to improve healthcare financial performance, showcasing its focus on expanding AI capabilities. These strategic moves, combined with the company’s addition to the S&P 100, have likely influenced its stock to rise 14% over the last quarter. Amid a broader market downturn with indexes such as the Nasdaq declining 8%, Palantir's stock performance stands out by capitalizing on its collaborative growth and market recognition despite challenges like a recent drop in earnings.

Buy, Hold or Sell Palantir Technologies? View our complete analysis and fair value estimate and you decide.

Outshine the giants: these 22 early-stage AI stocks could fund your retirement.

Over the past three years, Palantir Technologies has experienced a total shareholder return of a very large 486.81%, reflecting significant growth compared to industry averages. During the latest year, Palantir's return surpassed both the US Software industry and the broader US Market, with the industry at a 3% decline and the market at a 5.8% increase. Key factors underlying Palantir's long-term performance include several substantial partnerships, such as those with Oracle for secure cloud AI solutions and Everfox for enhancing national security software capabilities.

Additionally, Palantir's expanding AI capabilities through ventures like R37, an AI lab with R1, have been instrumental. The company's share repurchase program, which resulted in the buyback of over 2.12 million shares for US$64.2 million, further emphasized its commitment to investor value. The firm's inclusion in the S&P 100 Index has also elevated its market visibility and investor confidence, reinforcing Palantir's standing amid market fluctuations.

Upon reviewing our latest valuation report, Palantir Technologies' share price might be too optimistic.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGS:PLTR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com